7MRZ

Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment

Summary for 7MRZ

• Entry DOI: 10.2210/pdb7mrz/pdb
• Descriptor: Growth/differentiation factor 11, Activin receptor type-2B,Activin receptor type-1B, Fab Heavy Chain, ... (6 entities in total)
• Functional Keywords: growth factor, type i receptor, transforming growth factor beta, type ii receptor, ternary complex, gdf11, signaling protein, signaling protein-immune system complex, signaling protein/immune system
• Biological source: Homo sapiens (human); More
• Total number of polymer chains: 4
• Total formula weight: 88371.92

Authors

Goebel, E.J.,Kattamuri, C.,Gipson, G.R.,Thompson, T.B. (deposition date: 2021-05-10, release date: 2022-01-19, Last modification date: 2024-10-30)

Primary citation

Goebel, E.J.,Kattamuri, C.,Gipson, G.R.,Krishnan, L.,Chavez, M.,Czepnik, M.,Maguire, M.C.,Grenha, R.,Hakansson, M.,Logan, D.T.,Grinberg, A.V.,Sako, D.,Castonguay, R.,Kumar, R.,Thompson, T.B.
Structures of activin ligand traps using natural sets of type I and type II TGF beta receptors.
Iscience, 25:103590-103590, 2022

PubMed Abstract: The 30+ unique ligands of the TGFβ family signal by forming complexes using different combinations of type I and type II receptors. Therapeutically, the extracellular domain of a single receptor fused to an Fc molecule can effectively neutralize subsets of ligands. Increased ligand specificity can be accomplished by using the extracellular domains of both the type I and type II receptor to mimic the naturally occurring signaling complex. Here, we report the structure of one "type II-type I-Fc" fusion, ActRIIB-Alk4-Fc, in complex with two TGFβ family ligands, ActA, and GDF11, providing a snapshot of this therapeutic platform. The study reveals that extensive contacts are formed by both receptors, replicating the ternary signaling complex, despite the inherent low affinity of Alk4. Our study shows that low-affinity type I interactions support altered ligand specificity and can be visualized at the molecular level using this platform.

PubMed: 35005539
DOI: 10.1016/j.isci.2021.103590

Experimental method

X-RAY DIFFRACTION (3 Å)